<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3411564</article-id><article-id pub-id-type="pmid">22870274</article-id><article-id pub-id-type="publisher-id">PONE-D-12-12318</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0042002</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Diagnostic Medicine</subject></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Clinical Epidemiology</subject><subject>Genetic Epidemiology</subject><subject>Infectious Disease Epidemiology</subject><subject>Molecular Epidemiology</subject><subject>Social Epidemiology</subject><subject>Spatial Epidemiology</subject></subj-group></subj-group><subj-group><subject>Global Health</subject></subj-group><subj-group><subject>Infectious diseases</subject><subj-group><subject>Viral diseases</subject><subj-group><subject>Hepatitis</subject><subj-group><subject>Hepatitis C</subject></subj-group></subj-group></subj-group><subj-group><subject>Infectious Disease Control</subject></subj-group></subj-group><subj-group><subject>Oncology</subject></subj-group><subj-group><subject>Public Health</subject><subj-group><subject>Disease Ecology</subject><subject>Environmental Health</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Phylogeography, Risk Factors and Genetic History of Hepatitis C Virus in Gabon, Central Africa </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">Phylogeography of HCV Infection in Central Africa</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Njouom</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Caron</surname><given-names>Mélanie</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Besson</surname><given-names>Guillaume</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ndong-Atome</surname><given-names>Guy-Roger</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Makuwa</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pouillot</surname><given-names>Régis</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Nkoghé</surname><given-names>Dieudonné</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Leroy</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kazanji</surname><given-names>Mirdad</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Centre International de Recherches Médicales de Franceville, Franceville, Gabon</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Centre Pasteur du Cameroun, Réseau International des Instituts Pasteur, Yaoundé, Cameroon</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Ministère de la Santé, Libreville, Gabon</addr-line>
</aff><aff id="aff5">
<label>5</label>
<addr-line>Institut Pasteur de Bangui, Réseau International des Instituts Pasteur, Bangui, Central African Republic</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Bowyer</surname><given-names>Sheila Mary</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Pretoria/NHLS TAD, South Africa</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>mirdad.kazanji@pasteur.fr</email></corresp><fn fn-type="COI-statement"><p><text><SENT sid="1" pm="."><plain>Competing Interests: The authors received funding from Total-Gabon; however, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. </plain></SENT>
</text></p></fn><fn fn-type="con"><p><text><SENT sid="2" pm="."><plain>Conceived and designed the experiments: RN MC MK. </plain></SENT>
<SENT sid="3" pm="."><plain>Performed the experiments: RN MC GB G-RNA MM DN. </plain></SENT>
<SENT sid="4" pm="."><plain>Analyzed the data: RN MC RP MK. </plain></SENT>
<SENT sid="5" pm="."><plain>Contributed reagents/materials/analysis tools: DN EL. </plain></SENT>
<SENT sid="6" pm="."><plain>Wrote the paper: RN MC MM DN GB EL MK. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>1</day><month>8</month><year>2012</year></pub-date><volume>7</volume><issue>8</issue><elocation-id>e42002</elocation-id><history><date date-type="received"><day>30</day><month>4</month><year>2012</year></date><date date-type="accepted"><day>28</day><month>6</month><year>2012</year></date></history><permissions><copyright-statement>© 2012 Njouom et al</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Njouom et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title><text><SENT sid="7" pm="."><plain>Background </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="8" pm="."><plain>The epidemiological and molecular characteristics of hepatitis C virus (HCV) infection in the general population have been poorly investigated in Africa. </plain></SENT>
<SENT sid="9" pm="."><plain>The aim of this study was to determine the prevalence, genotype distribution and epidemic history of HCV in the Gabonese general population. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="10" pm="."><plain>Methods/Principal Findings </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="11" pm="."><plain>A total of 4042 sera collected from adults in 220 villages in all nine administrative areas of the country were screened for antibodies to HCV. </plain></SENT>
<SENT sid="12" pm="."><plain>HCV NS5B region sequencing was performed for molecular characterization and population genetic analyses. </plain></SENT>
<SENT sid="13" pm="."><plain>Of 4042 tested sera, 455 (11.2%) were positive. </plain></SENT>
<SENT sid="14" pm="."><plain>The seroprevalence of HCV varied significantly by administrative area, with the highest rate in Ogooué-Lolo province (20.4%) and the lowest in Ogooué-Maritine province (3.7%). </plain></SENT>
<SENT sid="15" pm="."><plain>History of parenteral injections, past hospital admission and age over 55 years were independent risk factors for HCV infection (p&lt;0.0001). </plain></SENT>
<SENT sid="16" pm="."><plain>Phylogenetic analyses showed that 91.9% of the strains were genotype 4 (HCV-4), 5.7% genotype 1 and 2.2% genotype 2. </plain></SENT>
<SENT sid="17" pm="."><plain>HCV-4 strains were highly heterogeneous, with more than eight subtypes; subtype 4e predominated (57.3%). </plain></SENT>
<SENT sid="18" pm="."><plain>Coalescence analyses indicated that subtype 4e was the oldest, with an estimated most recent common ancestor of 1702 [95% CI, 1418–1884]. </plain></SENT>
<SENT sid="19" pm="."><plain>The epidemic profile indicated that it spread exponentially during the first part of the 20th century, probably by iatrogenic transmission. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="20" pm="."><plain>Conclusions/Significance </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="21" pm="."><plain>These results confirm the endemicity of HCV subtype 4e in Gabon and show that its spread is due to a cohort effect, with previous, possibly iatrogenic events. </plain></SENT>
<SENT sid="22" pm="."><plain>More extensive epidemiological studies are needed to better characterize the route of transmission and the dissemination of HCV in Gabon. </plain></SENT>
</text></SecTag></p></sec></abstract><funding-group><funding-statement>The Centre International de Recherches Médicales de Franceville in Franceville, Gabon, is funded by the Gabonese Government, Total Gabon and the French Foreign Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="10"/></counts></article-meta></front><body><SecTag type="INTRO"><sec id="s1"><title><text><SENT sid="23" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="24" pm="."><plain>Hepatitis C virus (HCV) is a leading cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma [1]. </plain></SENT>
<SENT sid="25" pm="."><plain>HCV infects about 170 million people worldwide (3% of the world’s population) and is recognized as a major public health problem [2]. </plain></SENT>
<SENT sid="26" pm="."><plain>Like Egypt [3], Central Africa is considered a high-prevalence region, antibodies against HCV being detected in more than 6% of the population [4]. </plain></SENT>
<SENT sid="27" pm="."><plain>The highest prevalences in these countries are typically observed in the oldest population groups [5]–[10]. </plain></SENT>
</text></p><p><text><SENT sid="28" pm="."><plain>HCV evolves very rapidly, resulting in high genetic diversity. </plain></SENT>
<SENT sid="29" pm="."><plain>It is classified into six genotypes, each subdivided into multiple subtypes [11]. </plain></SENT>
<SENT sid="30" pm="."><plain>Some subtypes are found only in particular regions, while others are distributed globally. </plain></SENT>
<SENT sid="31" pm="."><plain>Genotype 1a is most commonly detected in Europe and the USA, while genotype 1b is distributed worldwide with high prevalences in Europe and the USA as well as in Japan. </plain></SENT>
<SENT sid="32" pm="."><plain>Genotype 2 originated from West and Central Africa and is common in Europe, Japan, and North America. </plain></SENT>
<SENT sid="33" pm="."><plain>Genotype 3 is most common in India, Indonesia and South-East Asia. </plain></SENT>
<SENT sid="34" pm="."><plain>Genotype 4 appears to be prevalent in Central Africa and the Middle East, while genotype 5 is most frequently reported in South Africa and genotype 6 in Hong Kong and South-East Asia [12]. </plain></SENT>
<SENT sid="35" pm="."><plain>The time of divergence of HCV genotypes circulating in those regions has been estimated: the age of the most recent common ancestor (MRCA) of genotypes 1 and 4 in Central Africa and of genotype 2 in West Africa was estimated to be 500–600 years [13]–[16], whereas the age of the MRCA of genotype 6 in East Asia was dated to 1100–1350 years [12], supporting the idea of long-term endemic transmission of HCV in these regions. </plain></SENT>
<SENT sid="36" pm="."><plain>Whereas circulation of most HCV subtypes remains restricted to geographical regions with long-term endemic transmission of the virus, a few HCV subtypes (1a, 1b, and 3a) are highly prevalent ‘epidemic’ strains that have spread outside the endemic regions and are distributed globally [17]. </plain></SENT>
<SENT sid="37" pm="."><plain>It has been estimated that epidemic subtypes 1a, 1b, and 3a emerged only about 100–150 years ago and started to spread exponentially during the 20th century [18]–[24]. </plain></SENT>
<SENT sid="38" pm="."><plain>Recent emergence and expansion is fully consistent with the idea that worldwide dissemination of the epidemic HCV subtypes is mainly due to the emergence of new, efficient routes of viral transmission during the 20th century, such as blood transfusion, hemodialysis, injection drug use, and non-sterile medical injections [23], [25], [26]. </plain></SENT>
</text></p><p><text><SENT sid="39" pm="."><plain>In Gabon, the epidemiological picture is based on a few population-based surveys conducted since 1993. </plain></SENT>
<SENT sid="40" pm="."><plain>A seroprevalence of more than 6.5% was reported in Gabon [6], [27], and the available sequences indicated a predominance of genotype 4 [6], [28]. </plain></SENT>
<SENT sid="41" pm="."><plain>The only study on the genetic diversity of HCV NS5B sequences in Gabon showed that subtype 4e predominated in the 22 samples, and evolutionary analysis of the 4e sequences indicates a period of increased transmission during the early 20th century [6]. </plain></SENT>
<SENT sid="42" pm="."><plain>These population-based surveys have, however, been restricted to small towns and are not representative of the general population. </plain></SENT>
<SENT sid="43" pm="."><plain>As large-scale population-based studies are not available in Gabon, the results cannot be used to estimate the prevalence of HCV infection, the genotype distribution or the burden of the disease in the general population. </plain></SENT>
</text></p><p><text><SENT sid="44" pm="."><plain>We present here the results of a population-based study in all nine provinces of Gabon. </plain></SENT>
<SENT sid="45" pm="."><plain>The purpose of the study was to determine the seroprevalence of HCV in a stratified sample (by age and geographical area) of the general rural population and to establish the distribution of viral subtypes. </plain></SENT>
<SENT sid="46" pm="."><plain>The epidemic history of HCV was deduced by analysis of independent sequences in the NS5B region with new coalescence techniques [22]. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="methods" id="s2"><title><text><SENT sid="47" pm="."><plain>Methods </plain></SENT>
</text></title><sec id="s2a"><title><text><SENT sid="48" pm="."><plain>Study Area and Population </plain></SENT>
</text></title><p><text><SENT sid="49" pm="."><plain>Gabon is located in central Africa, transversed by the equator; nearly 80% is covered by rain forest. </plain></SENT>
<SENT sid="50" pm="."><plain>The country has a surface area of 267 667 km2 with about 1.5 million inhabitants (5.6 inhabitants/km2), 73% of whom live in urban areas. </plain></SENT>
<SENT sid="51" pm="."><plain>Administratively, Gabon is divided into nine provinces with 2048 villages located mainly along roads and rivers; few have more than 300 inhabitants. </plain></SENT>
<SENT sid="52" pm="."><plain>The main activities are subsistence farming, hunting, gathering and fishing. </plain></SENT>
<SENT sid="53" pm="."><plain>This study was conducted on blood samples collected between June 2005 and September 2008, during a project on Ebola virus in Gabon [29]. </plain></SENT>
<SENT sid="54" pm="."><plain>Briefly, the survey covered 220 randomly selected villages in the nine administrative regions of Gabon (range, 10–41 villages per province), most of which were rural with fewer than 300 inhabitants. </plain></SENT>
<SENT sid="55" pm="."><plain>The multidisciplinary team comprised a doctor from the Gabonese Ministry of Health, a nurse, an epidemiologist, a virologist and laboratory technicians, who made nine 1-month field missions to the study villages. </plain></SENT>
<SENT sid="56" pm="."><plain>All healthy volunteers over 15 years old who had been residing in the village for more than 1 year were eligible for the study. </plain></SENT>
</text></p><p><text><SENT sid="57" pm="."><plain>The study protocol was reviewed and approved by the Gabonese Ministry of Health (Research authorization No. 00093/MSP/SG/SGAQM). </plain></SENT>
<SENT sid="58" pm="."><plain>The Health Director and the Governor of each province received written information, as did the traditional chief of each village. </plain></SENT>
<SENT sid="59" pm="."><plain>The planned studies were described orally to all participants, and individual written consent was obtained for blood sampling; parents’ written consent was obtained for participating children and minors. </plain></SENT>
<SENT sid="60" pm="."><plain>People who gave informed consent were interviewed on a structured epidemiological questionnaire covering history of blood transfusion, jaundice, mass treatment and mass vaccination, sharing toiletry items with other family members, suspected nosocomial transmission (surgical and dental procedures, hospitalizations) and suspected sporadic transmission (ritual scarring, ritual circumcision for men, ritual ear-piercing for women). </plain></SENT>
<SENT sid="61" pm="."><plain>A free medical examination and basic medicines were provided to all participants and non-participants. </plain></SENT>
<SENT sid="62" pm="."><plain>Blood smears for malaria diagnosis and field blood typing were also proposed. </plain></SENT>
</text></p><p><text><SENT sid="63" pm="."><plain>Blood samples were usually collected in the village health care centers into 7-ml Vacutainer tubes containing EDTA (VWR International, France). </plain></SENT>
<SENT sid="64" pm="."><plain>The tubes were transported to the field laboratory for centrifugation (10 min, 2000 × g) daily. </plain></SENT>
<SENT sid="65" pm="."><plain>Plasma and buffy coat were stored in aliquots at –20°C until the end of the field mission and then transferred on dry ice to the Centre International de Recherches Médicales de Franceville (CIRMF) and kept at –80°C until analysis. </plain></SENT>
<SENT sid="66" pm="."><plain>Each plasma sample was separated upon collection into two aliquots: one for serological testing and the other for molecular characterization. </plain></SENT>
</text></p></sec><sec id="s2b"><title><text><SENT sid="67" pm="."><plain>Serological Test </plain></SENT>
</text></title><p><text><SENT sid="68" pm="."><plain>The presence of antibodies to HCV was checked with a third-generation enzyme immunoassay (Monolisa anti-HCV plus version 2, Biorad, Marnes-La-Coquette, France). </plain></SENT>
<SENT sid="69" pm="."><plain>The reactivity of samples was determined as described previously [30]. </plain></SENT>
<SENT sid="70" pm="."><plain>Briefly, a ratio was calculated for each sample by dividing its optical density by the cut-off value. </plain></SENT>
<SENT sid="71" pm="."><plain>A sample was scored as positive if the ratio was ≥6, whereas all samples with a ratio &lt;6 were scored as negative. </plain></SENT>
</text></p></sec><sec id="s2c"><title><text><SENT sid="72" pm="."><plain>HCV Genotyping and Subtyping </plain></SENT>
</text></title><p><text><SENT sid="73" pm="."><plain>HCV genotyping and subtyping were performed by amplification, sequencing and phylogenetic analysis of a 382-nt fragment of the NS5B gene. </plain></SENT>
<SENT sid="74" pm="."><plain>Briefly, viral RNA was extracted from 140 µl of plasma from HCV-positive individuals with a QIAamp Viral RNA Mini Kit according to the manufacturer's protocol (Qiagen, Courtaboeuf, France). </plain></SENT>
<SENT sid="75" pm="."><plain>The portion of HCV NS5B gene from extracted RNA was further amplified and sequenced as described previously [31]. </plain></SENT>
<SENT sid="76" pm="."><plain>Briefly, RNA was subjected to hemi-nested polymerase chain reaction (PCR) amplification, with Pr3 (5′-TATGAYACCCGCTGYTTTGCTC-3′) and Pr4 (5′-GCNGARTAYCTVGTCATAGCCTC-3′) as primers in the first step and Pr3 and Pr5 (5′-GCTAGTCATAGCCTCCGT-3′) in the second step. </plain></SENT>
<SENT sid="77" pm="."><plain>Combined reverse transcriptase (RT)-PCR was carried out on 10 µl of extracted RNA (reaction mixture volume, 50 µl) with the one-step RT-PCR kit (Superscript III) and 200 nM of each primer (Pr3, Pr4 and Pr5). </plain></SENT>
<SENT sid="78" pm="."><plain>The first step of RT-PCR with Pr3 and Pr4 was carried out at 50°C for 30 min, then five cycles at 93°C for 30 s, 60°C for 45 s and 72°C for 1 min, followed immediately by 35 cycles at 93°C for 30 s, 60°C with a drop of −0.3°C between each cycle and elongation at 72°C for 1 min. </plain></SENT>
<SENT sid="79" pm="."><plain>The final elongation was at 72°C for 5 min. </plain></SENT>
<SENT sid="80" pm="."><plain>The second amplification step with Pr3 and Pr5 was carried out on 2 µl of the first PCR products at 95°C for 5 min, then 35 cycles at 95°C for 30 s, 55°C for 30 s, 72°C for 30 s and a final elongation at 72°C for 10 min. </plain></SENT>
<SENT sid="81" pm="."><plain>The amplified NS5B 382-bp product was analyzed by electrophoresis with a 2% agarose gel and ethidium bromide staining. </plain></SENT>
<SENT sid="82" pm="."><plain>PCR products were purified on columns (Quick-Spin™ Qiagen, Hilden, Germany) and sequenced. </plain></SENT>
<SENT sid="83" pm="."><plain>PCR primers (Pr3 and Pr5) were used for sequencing both DNA strands. </plain></SENT>
<SENT sid="84" pm="."><plain>Cycle sequencing was undertaken by the fluorescent dye terminator technique (Big Dye Terminator Cycle sequencing; Applied Biosystems, Courtaboeuf, France) with Ampli Taq™ DNA polymerase according to the manufacturer's instructions. </plain></SENT>
<SENT sid="85" pm="."><plain>Electrophoresis and data collection were done on an Applied Biosystems ABI 3100 Genetic Analyzer. </plain></SENT>
<SENT sid="86" pm="."><plain>Sequence chromatograph files were analyzed with sequence analysis™ and sequence navigator™ software. </plain></SENT>
</text></p><p><text><SENT sid="87" pm="."><plain>For phylogenetic analysis, NS5B nucleotide sequences were aligned initially by CLUSTAL_X 1.81 [32] and subsequently adjusted by hand. </plain></SENT>
<SENT sid="88" pm="."><plain>The sequences were compared with reference sequences from the European HCV database (<ext-link ext-link-type="uri" xlink:href="http://euhcvdb.ibcp.fr/euHCVdb/">http://euhcvdb.ibcp.fr/euHCVdb/</ext-link>) and the Los Alamos database (<ext-link ext-link-type="uri" xlink:href="http://hcv.lanl.gov/">http://hcv.lanl.gov/</ext-link>). </plain></SENT>
<SENT sid="89" pm="."><plain>Phylogenetic trees were estimated and assessed by the bootstrapping and neighbor-joining methods under the Kimura two-parameter substitution model, as implemented in MEGA version 5.0 [33]. </plain></SENT>
<SENT sid="90" pm="."><plain>Bootstrapping was performed with 1000 replicates. </plain></SENT>
</text></p><p><text><SENT sid="91" pm="."><plain>In order to confirm the results obtained by NS5B genotyping and to identify probable recombinant HCV isolates, a 360-nucleotide fragment of the core gene was amplified as described previously [34] from a set of randomly selected samples. </plain></SENT>
<SENT sid="92" pm="."><plain>Briefly, RNA was subjected to a nested PCR amplification with CoreOS (5′-ACTGCCTGATAGGGTGCTTGCGAG-3′) and CoreOAS (5′-ATGTACCCCATGAGGTCGGC-3′) as the primers in the first step and CoreIS (5′-AGGTCTCGTAGACCGTGCATCATG-3′) and CoreIAS (5′-CAYGTRAGGGTATCGATGAC-3′) in the second step. </plain></SENT>
<SENT sid="93" pm="."><plain>cDNA synthesis was first was carried out on 10 µl of extracted RNA (reaction mixture volume, 20 µl) with the RT kit (AMV-RT, Promega) and a random hexamer. </plain></SENT>
<SENT sid="94" pm="."><plain>The first step of PCR with CoreOS and CoreOAS and the second PCR with CoreIS and CoreIAS were carried out at 94°C for 3 min, then two cycles at 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s, followed immediately by two of the same cycles with a drop of −1°C at each hybridation cycle until 51°C and then 20 cycles of 95°C for 30 s and 50°C for 30 s, with a final elongation at 72°C for 7 min. </plain></SENT>
<SENT sid="95" pm="."><plain>The amplified core 360-bp product was analyzed by electrophoresis on a 2% agarose gel with ethidium bromide staining. </plain></SENT>
<SENT sid="96" pm="."><plain>The PCR products were purified and sequenced as described above. </plain></SENT>
<SENT sid="97" pm="."><plain>The PCR primers CoreIS and CoreIAS were used for sequencing both DNA strands. </plain></SENT>
</text></p></sec><sec id="s2d"><title><text><SENT sid="98" pm="."><plain>Coalescent Analysis </plain></SENT>
</text></title><p><text><SENT sid="99" pm="."><plain>The epidemic history of HCV subtypes 4e, 4f, 4c, 4t, and 4k, the prevalences of which represent at least 5% of circulating HCV isolates in Gabon, was investigated with a coalescent-based strategy. </plain></SENT>
<SENT sid="100" pm="."><plain>Briefly, HCV demographic history was inferred by Bayesian Monte Carlo Markov Chain (MCMC) analysis in BEAST 1.4 software (<ext-link ext-link-type="uri" xlink:href="http://.beast.bio.ed.ac.uk">http://.beast.bio.ed.ac.uk</ext-link>), as described elsewhere [14]. </plain></SENT>
<SENT sid="101" pm="."><plain>We used an informative prior normal distribution, with a mean of 5.0 × 10–4 and a standard deviation of 7.14 × 10–5. </plain></SENT>
<SENT sid="102" pm="."><plain>This distribution represents a best estimate of HCV NS5B evolutionary rates, as obtained from two independent prior analyses [22], [24]. </plain></SENT>
<SENT sid="103" pm="."><plain>As recommended, a relaxed molecular clock approach (uncorrelated lognormal model) was used, thereby taking into account the variation in evolutionary rate among lineages [35]. </plain></SENT>
<SENT sid="104" pm="."><plain>BEAST output files were analyzed with TRACER 1.3 (<ext-link ext-link-type="uri" xlink:href="http://tree.bio.ed.ac.uk/software/tracer/">http://tree.bio.ed.ac.uk/software/tracer/</ext-link>). </plain></SENT>
</text></p></sec><sec id="s2e"><title><text><SENT sid="105" pm="."><plain>Statistical Analysis </plain></SENT>
</text></title><p><text><SENT sid="106" pm="."><plain>Statistical analysis was performed with Epi-Info (version 6.04dfr, ENSP-Epiconcept-InUS, 2001). </plain></SENT>
<SENT sid="107" pm="."><plain>The overall prevalence was checked by the chi-squared test with Yates correction. p values &lt;0.05 were considered statistically significant. </plain></SENT>
<SENT sid="108" pm="."><plain>Data were then analyzed by logistic regression. </plain></SENT>
<SENT sid="109" pm="."><plain>The continuous variable age was categorized and entered into the model. </plain></SENT>
<SENT sid="110" pm="."><plain>The strength of the association between age and HCV infection was estimated in the multivariate analyses as odds ratios (ORs) with 95% confidence intervals (CIs). </plain></SENT>
</text></p></sec><sec id="s2f"><title><text><SENT sid="111" pm="."><plain>Nucleotide Sequence Accession Numbers </plain></SENT>
</text></title><p><text><SENT sid="112" pm="."><plain>The nucleotide sequences obtained from the core and NS5B gene of HCV were assigned GenBank accession numbers JN642718–JN642776 (59 sequences) and JN642777–JN642987 (211 sequences), respectively. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec id="s3"><title><text><SENT sid="113" pm="."><plain>Results </plain></SENT>
</text></title><sec id="s3a"><title><text><SENT sid="114" pm="."><plain>Study Population </plain></SENT>
</text></title><p><text><SENT sid="115" pm="."><plain>We enrolled 4042 people in 220 randomly selected villages covering all nine administrative areas of the country (Figure 1). </plain></SENT>
<SENT sid="116" pm="."><plain>Blood samples and sociodemographic data were collected from all participants. </plain></SENT>
<SENT sid="117" pm="."><plain>The mean age ± SD of the study population was 47±14.3 years (range, 15–90 years) (Table 1), and the sex distribution was 2180 (53.9%) females and 1860 (46.1%) males. </plain></SENT>
<SENT sid="118" pm="."><plain>There was no significant difference in mean age by province. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0042002-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0042002.g001</object-id><label>Figure 1</label><caption><title><text><SENT sid="119" pm="."><plain>Map of Gabon with administrative regions, prevalence of antibodies to HCV and predominant subtypes. </plain></SENT>
</text></title></caption><graphic xlink:href="pone.0042002.g001"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="pone-0042002-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0042002.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="120" pm="."><plain>Distribution and mean age of study population in the nine administrative areas of Gabon. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0042002-t001-1" xlink:href="pone.0042002.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="121" pm="."><plain>Province </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="122" pm="."><plain>Number of participants </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="123" pm="."><plain>Mean age ± SD (years) </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="124" pm="."><plain>Estuaire </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="125" pm="."><plain>314 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="126" pm="."><plain>46±12.7 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="127" pm="."><plain>Haut Ogooué </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="128" pm="."><plain>363 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="129" pm="."><plain>45±13.3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="130" pm="."><plain>Moyen Ogooué </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="131" pm="."><plain>676 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="132" pm="."><plain>45±14.7 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain>Ngounié </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>303 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>48±14.4 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain>Nyanga </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>422 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>46±12.0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>Ogooué Ivindo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>457 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>46±14.6 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>Ogooué Lolo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>423 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>52±13.9 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>Ogooué Maritime </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>187 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>50±18.7 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>Woleu Ntem </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>897 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>47±14.6 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>Total </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>4042 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>47±14.3 </plain></SENT>
</text></td></tr></tbody></table></alternatives></table-wrap></SecTag></sec><sec id="s3b"><title><text><SENT sid="154" pm="."><plain>HCV Seroprevalence, Regional and Age Distribution and Risk Factors for Infection </plain></SENT>
</text></title><p><text><SENT sid="155" pm="."><plain>The seroprevalence of HCV in the study population was 11.2% (95% CI, 10.3–12.3) (Table 2), with no significant difference between females (11.0%; 95% CI, 9.7–12.4) and males (11.6%; 95% CI, 10.2–13.2). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0042002-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0042002.t002</object-id><label>Table 2</label><caption><title><text><SENT sid="156" pm="."><plain>Prevalence of hepatitis C virus infection according to age group and administrative area in Gabon. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0042002-t002-2" xlink:href="pone.0042002.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td colspan="11" align="left" rowspan="1"><text><SENT sid="157" pm="."><plain>Number of people with antibodies to HCV/number of people tested </plain></SENT>
</text></td></tr><tr><td colspan="11" align="left" rowspan="1"><text><SENT sid="158" pm="."><plain>(%; 95% confidence interval) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>Age(years) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>Estuaire </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>Haut Ogooué </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>Moyen Ogooué </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>Ngounié </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>Nyanga </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>O. </plain></SENT>
<SENT sid="166" pm="."><plain>Ivindo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>O. </plain></SENT>
<SENT sid="168" pm="."><plain>Lolo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>O. </plain></SENT>
<SENT sid="170" pm="."><plain>Maritime </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>Woleu Ntem </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>Total </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>≤25 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>1/26 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>0/38 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>0/75 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>1/29 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>3/32 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>0/58 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>0/17 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>0/17 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>1/79 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>6/371 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain>(3.8;0.1–19.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>(0.0;0.0–9.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>(0.0;0.0–4.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>(3.4;0.09–17.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="188" pm="."><plain>(9.4;2.0–25.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="189" pm="."><plain>(0.0;0.0–9.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="190" pm="."><plain>(0.0;0.0–19.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="191" pm="."><plain>(0.0;0.0–19.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>(1.3;0.0–6.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>(1.6;0.6–3.5) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>26–35 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>2/45 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>0/56 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>2/132 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>2/34 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>2/65 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>0/67 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>2/50 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>0/41 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>0/127 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain>10/617 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="205" pm="."><plain>(4.4;0.5–15.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>(0.0;0.0–6.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="207" pm="."><plain>(1.5;0.2–5.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="208" pm="."><plain>(5.9;0.7–19.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="209" pm="."><plain>(3.1;0.4–10.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="210" pm="."><plain>(0.0;0.0–5.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="211" pm="."><plain>(4.0;0.5–13.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="212" pm="."><plain>(0.0;0.0–8.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="213" pm="."><plain>(0.0;0.0–2.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="214" pm="."><plain>(1.6;0.8–3.0) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>36–45 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>3/74 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>3/76 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>3/127 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>4/51 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="220" pm="."><plain>6/79 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="221" pm="."><plain>3/86 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="222" pm="."><plain>9/77 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="223" pm="."><plain>0/23 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain>10/166 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>42/759 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>(4.1;0.8–11.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>(3.9;0.8–11.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>(2.4;0.5–6.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>(7.8;2.2–18.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>(7.6;2.8–15.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>(3.5;0.7–9.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>(11.7;5.5–21.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>(0.0;0.0–14.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>(6.0;2.9–10.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>(5.5;4.0–7.4) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>46–55 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>9/87 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>16/80 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>10/136 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>13/67 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>18/131 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>8/113 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>17/70 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>2/30 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>16/184 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>111/898 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>(10.3;4.8–18.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>(20.0;11.9–30.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>(7.4;3.6–13.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>(19.4;10.8–30.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>(13.7;8.4–20.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>(7.1;3.1–13.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>(24.3;14.8–36.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>(6.7;0.8–22.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>(8.7;5.1–13.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>(12.4;10.3–14.7) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>&gt;55 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>25/82 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>28/113 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>23/206 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>22/122 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>31/115 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>29/133 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>60/209 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>5/78 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>63/341 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>286/1397 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>(30.5;20.8–41.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>(24.8;17.1–33.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>(11.2;7.2–16.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>(18.0;11.7–26.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>(27.0;19.1–36.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>(21.8;15.1–29.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>(28.7;22.7–35.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>(6.4;2.1–14.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>(18.5;14.5–23.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>(20.5;18.4–22.7) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>Total </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>40/314 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>48/363 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>38/676 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>44/303 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>60/422 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>40/457 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>88/423 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>7/187 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>90/897 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>455/4042 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>(12.7;9.3–16.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>(13.2;9.9–17.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>(5.6;4.0–7.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>(14.5;10.8–19.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>(14.2;11.0–17.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="294" pm="."><plain>(8.7;6.3–11.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>(20.8;17.0–25.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>(3.7;1.5–7.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>(10.0;8.1–12.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="298" pm="."><plain>(11.2;10.3–12.3) </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><p><text><SENT sid="299" pm="."><plain>O, Ogooué. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="300" pm="."><plain>The seroprevalence of HCV varied significantly according to administrative area (Figure 1, Table 2). </plain></SENT>
<SENT sid="301" pm="."><plain>The seroprevalence in Ogooué-Lolo province (20.8%; 95% CI, 17.0–25.0) was significantly higher than that in the other provinces (p&lt;0.001), while that in Ogooué-Maritime province (3.7%; 95% CI, 1.5–7.6) was significantly lower (p&lt;0.001). </plain></SENT>
<SENT sid="302" pm="."><plain>Four patterns of seroprevalence were found (Figure 1): &lt;5% (Ogooué-Maritime), 5–10% (Moyen-Ogooué, Ogooué-Ivindo and Woleu-Ntem), 11–15% (Estuaire, Nyanga, Ngounié, and Haut-Ogooué), and &gt;15% (Ogooué-Lolo). </plain></SENT>
</text></p><p><text><SENT sid="303" pm="."><plain>As shown in Table 2, the seroprevalence increased with age, from 1.6% in the &lt;25-year age group to 12.4% at 46–55 years and 20.5% at &gt;55 years (chi squared test for trend, p&lt;0.001). </plain></SENT>
<SENT sid="304" pm="."><plain>This trend was similar in all geographical areas, with significant increases with increasing age, the highest prevalence being in the &gt;55-year age group. </plain></SENT>
</text></p><p><text><SENT sid="305" pm="."><plain>Univariate analysis of risk factors for HCV infection among seropositive and seronegative people showed that the independent predictors of positivity for HCV antibodies were a history of parenteral injections (p&lt;0.0001; OR, 1.86; 95% CI, 1.52–2.28), past hospital admission (p&lt;0.0001; OR, 1.42; 95% CI, 1.15–1.75) and age &gt;55 years (p&lt;0.0001; OR, 3.77; 95% CI, 3.08–4.62) (Table 3). </plain></SENT>
<SENT sid="306" pm="."><plain>The same analyses were done separately for each administrative area, with similar results (data not shown, available upon request). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0042002-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0042002.t003</object-id><label>Table 3</label><caption><title><text><SENT sid="307" pm="."><plain>Univariate analysis of risk factors for HCV infection among HCV-positive and HCV-negative individuals. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0042002-t003-3" xlink:href="pone.0042002.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>Risk factor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>HCV positive, N (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>HCV negative, N (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>OR [95% CI]* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>p </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>Gender </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>Male </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>216 (11.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>1644 (88.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>1.00† </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>&gt;0.05 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>Female </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>239 (11.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>1941 (89.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>0.94 [0.77; 1.14] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>Age (years) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>≤55 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>169 (6.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>2476 (93.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>1.00† </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>&lt;0.001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>&gt;55 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>286 (20.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>1111 (79.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>3.77 [3.08; 4.62] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>Blood or blood product transfusion </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>404 (11.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>3138 (88.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>1.00† </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>&gt;0.05 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>41 (10.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>351 (89.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>0.91 [0.65; 1.28] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>Past hospital admission </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>144 (9.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>1402 (90.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>1.00† </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>&lt;0.001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>305 (12.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>2091 (87.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>1.42 [1.15; 1.75] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>History of parenteral injections </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>270 (9.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>2577 (90.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>1.00† </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>&lt;0.001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>180 (16.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>923 (83.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>1.86 [1.52; 2.28] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>Jaundice </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>66 (7.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>777 (92.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>1.00† </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>&gt;0.05 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>7 (11.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>54 (88.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>1.53 [0.67; 3.50] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>Traditional scarification </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>230 (12.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>1693 (88.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>1.00† </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>&gt;0.05 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>220 (10.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>1805 (89.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>0.90 [0.74; 1.10] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt102"><label>*</label><p><text><SENT sid="383" pm="."><plain>OR, odds ratio; CI, confidential interval; †, reference. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="s3c"><title><text><SENT sid="384" pm="."><plain>HCV Genotype and Subtype Distribution </plain></SENT>
</text></title><p><text><SENT sid="385" pm="."><plain>HCV RNA in the NS5B region could be amplified, sequenced and analysed phylogenetically from 211 of the 455 HCV-seropositive participants (46.4%). Figure 2 shows the estimated phylogeny of these and previously published HCV NS5B sequences. </plain></SENT>
<SENT sid="386" pm="."><plain>Of the 211 HCV samples, 194 (91.9%) were genotype 4 (HCV-4), 12 (5.7%) were genotype 1, and five (2.2%) were genotype 2. </plain></SENT>
<SENT sid="387" pm="."><plain>Within genotype 4, more than half the sequences (121, 57.3%) were in one cluster, i.e. reference 4e subtype sequences; 21 (9.9%) were associated with 4c sequences, 21 (9.9%) with 4f, 11 (5.2%) with 4t, 10 (4.7%) with 4k, 4 (1.9%) with 4r, and 3 (1.4%) with 4g. </plain></SENT>
<SENT sid="388" pm="."><plain>The remaining three (1.3%) sequences did not cluster with current subtype HCV-4 sequences. </plain></SENT>
<SENT sid="389" pm="."><plain>Within genotype 1, a cluster of five sequences (41.7%) corresponded to subtype 1e and four (33.3%) to 1h. </plain></SENT>
<SENT sid="390" pm="."><plain>Two sequences were subtyped as 1l, and one was an unclassified HCV-1 subtype. </plain></SENT>
<SENT sid="391" pm="."><plain>The five HCV genotype 2 sequences formed a monophyletic cluster and were unclassified. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0042002-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0042002.g002</object-id><label>Figure 2</label><caption><title><text><SENT sid="392" pm="."><plain>Phylogram depicting the phylogenetic relations between partial (380-bp) HCV NS5B sequences obtained in this study and representative sequences of HCV genotypes fromGenBank. </plain></SENT>
</text></title><p><text><SENT sid="393" pm="."><plain>The sequences from this study are shown in bold and grouped in their corresponding clusters. </plain></SENT>
<SENT sid="394" pm="."><plain>Percentage bootstrap values (&gt;70%) are shown at the respective nodes. </plain></SENT>
<SENT sid="395" pm="."><plain>All 211 sequences were submitted to GenBank with the accession numbers JN642777–JN642987. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0042002.g002"/></fig></SecTag><p><text><SENT sid="396" pm="."><plain>The genotype/subtype distribution of 211 HCV-RNA positive samples according to geographical area is shown in Table 4. </plain></SENT>
<SENT sid="397" pm="."><plain>Except in Woleu-Ntem province, subtype 4e was the most prevalent. </plain></SENT>
<SENT sid="398" pm="."><plain>In some provinces, particularly those located in the centre of the country, subtype 4e was found in more than 50% of the typed samples. </plain></SENT>
<SENT sid="399" pm="."><plain>In the provinces in which subtype 4e represented less than 50% of subtypes, a high level of co-circulation (&gt;20%) with other subtypes of genotype 4 was observed. </plain></SENT>
<SENT sid="400" pm="."><plain>These provinces were principally those that border other central African countries, i.e Woleu-Ntem and Estuaire bordering Cameroon with subtype 4f and Haut-Ogooué bordering the Republic of Congo with subtype 4c (Figure 1 and Table 4). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0042002-t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0042002.t004</object-id><label>Table 4</label><caption><title><text><SENT sid="401" pm="."><plain>Distribution of hepatitis C virus genotypes and subtypes according to administrative area in Gabon. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0042002-t004-4" xlink:href="pone.0042002.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="10" align="left" rowspan="1"><text><SENT sid="402" pm="."><plain>Number of positive samples (% prevalence) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>HCVgénotypeor subtype </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>Estuaire(N  = 28) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>Haut Ogooué(N  = 27) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>Moyen Ogooué(N  = 29) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>Ngounié(N  = 25) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>Nyanga(N  = 24) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>Ogooué Ivindo(N  = 25) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>OgoouéLolo(N  = 24) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>WoleuNtem(N  = 24) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>Ogooué Maritime(N  = 5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>Total(N  = 211) </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>4e </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>11 (39.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>13 (48.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>17 (56.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>22 (88.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>19 (79.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>14 (56.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>16 (66.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>6 (25.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>3 (60.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>121 (57.3) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>4c </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>1 (3.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>9 (33.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>1 (3.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>1 (4.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>4 (16.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>5 (20.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>21 (9.9) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>4f </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="437" pm="."><plain>8 (28.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>2 (6.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>1 (4.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>2 (8.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>1 (4.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>7 (29.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>21 (9.9) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>4t </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>2 (7.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>2 (6.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>1 (4.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>1 (4.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>5 (20.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>11 (5.2)) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>4k </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>3 (10.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>3 (10.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>2 (8.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="463" pm="."><plain>2 (8.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>10 (4.7) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>4r </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>1 (3.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>2 (7.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>1 (4.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>4 (1.9) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>4g </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>2 (8.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>1 (20.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>3 (1.4) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>4un </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>2 (7.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>1 (4.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>3 (1.4) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="502" pm="."><plain>1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>2 (7.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>2 (6.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>1 (4.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>6 (25.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>1 (20.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>12 (5.7) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>1 (3.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>2 (6.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>2 (8.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>5 (2.4) </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><p><text><SENT sid="524" pm="."><plain>N, number of samples tested. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="525" pm="."><plain>To validate the genotype/subtype assignment based on analysis of the NS5B region, sequence analysis was performed on the core region for 59 randomly selected isolates. </plain></SENT>
<SENT sid="526" pm="."><plain>The phylogenetic tree (data not shown) confirmed the subtype assignment for all isolates. </plain></SENT>
</text></p></sec><sec id="s3d"><title><text><SENT sid="527" pm="."><plain>Epidemic History of the Commonest Subtypes of HCV Circulating in Gabon </plain></SENT>
</text></title><p><text><SENT sid="528" pm="."><plain>In order to investigate the origin and spread of HCV-4 in this population more carefully, subtypes with at least 10 NS5B sequences (4e, 4f, 4c, 4t, and 4k) were selected, and the divergence date and epidemic history were estimated with a Bayesian coalescent approach. </plain></SENT>
</text></p><p><text><SENT sid="529" pm="."><plain>Table 5 shows the date of the MRCA for the five most prevalent Gabonese HCV-4 subtypes. </plain></SENT>
<SENT sid="530" pm="."><plain>Subtype 4e strain was the oldest, with an estimated MRCA date of 1702 (95% CI, 1418–1884); the dates of the 4f, 4c and 4t MRCAs were in the same range and were estimated to be 1888 (95% CI, 1855–1915), 1881 (95% CI, 1813–1930), and 1875 (95% CI, 1820–1918), respectively, while the 4k MRCA appeared to be more recent (1944; 95% CI, 1922–1962). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0042002-t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0042002.t005</object-id><label>Table 5</label><caption><title><text><SENT sid="531" pm="."><plain>Descriptive statistics from the empirical posterior distribution of the date of the most recent common ancestors (MRCAs) of Gabonese HCV NS5B partial sequences according to HCV-4 subtype. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0042002-t005-5" xlink:href="pone.0042002.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>Subtype </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>n </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>Median date (years) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>95% CI date (years) </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>4e </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>121 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>1702 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>1418–1884 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>4f </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>21 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>1888 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="543" pm="."><plain>1855–1915 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>4c </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>21 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>1881 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>1813–1930 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>4t </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>1875 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="551" pm="."><plain>1820–1918 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="552" pm="."><plain>4k </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="553" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="554" pm="."><plain>1944 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="555" pm="."><plain>1922–1962 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt104"><p><text><SENT sid="556" pm="."><plain>These distributions were obtained by Bayesian inferences with BEAST software, with a normal posterior distribution of the mean mutation rate at a mean of 5×104 and a standard deviation of 7.14×105. </plain></SENT>
<SENT sid="557" pm="."><plain>95% credible confidence intervals are delimited by the 0.025th and 0.975th quantiles. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="558" pm="."><plain>The Bayesian skyline plot (Figure 3) depicts the estimated change in the effective number of infected individuals over time, from the HCV-4 MRCA to the year of sampling. </plain></SENT>
<SENT sid="559" pm="."><plain>Two patterns of epidemic history were observed. </plain></SENT>
<SENT sid="560" pm="."><plain>The first was that of HCV 4e, 4f, and 4c, the epidemic history of which was characterized by three phases of population growth: an initial period of relatively constant population size, a period of exponential growth during the first part of the 20th century and, finally, slower exponential growth. </plain></SENT>
<SENT sid="561" pm="."><plain>The second pattern was that of HCV 4t and 4k, which was characterized by one phase of population growth, including a period of exponential growth during the first part of the 20th century. </plain></SENT>
<SENT sid="562" pm="."><plain>The epidemic history of 4c precedes that of 4e and 4f by several decades. </plain></SENT>
<SENT sid="563" pm="."><plain>While the 4c population increased exponentially between 1950 and 1980, the 4e and 4f populations experienced exponential growth between 1920 and 1960. </plain></SENT>
<SENT sid="564" pm="."><plain>In contrast, the 4t and 4k populations did not reach growth equilibrium during this period. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0042002-g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0042002.g003</object-id><label>Figure 3</label><caption><title><text><SENT sid="565" pm="."><plain>Bayesian skyline plots estimated for HCV subtypes 4e, 4f, 4c, 4t, and 4k in Gabon. </plain></SENT>
</text></title><p><text><SENT sid="566" pm="."><plain>The middle line is the median estimate of effective population size, and the envelope shows the 95% highest posterior density interval of this estimate. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0042002.g003"/></fig></SecTag></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="s4"><title><text><SENT sid="567" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="568" pm="."><plain>We report here the largest HCV seroepidemiological study performed in Gabon so far, with 4042 blood samples from all nine provinces of the country. </plain></SENT>
<SENT sid="569" pm="."><plain>Overall, the seroprevalence of HCV was 11.2%, thus confirming a high prevalence of HCV infection in Gabon. </plain></SENT>
<SENT sid="570" pm="."><plain>Its heterogeneity (ranging from 3.7% to 20.8%) depended on the area studied. </plain></SENT>
<SENT sid="571" pm="."><plain>Studies in other countries have also reported significant intra-country variation in HCV prevalence [36]–[40]. </plain></SENT>
<SENT sid="572" pm="."><plain>The design of our study allowed investigation of HCV infection according to sex and age; no statistically significant difference in HCV distribution was found according to sex, as for community-acquired hepatitis C in other regions of the world [41]–[43]. </plain></SENT>
<SENT sid="573" pm="."><plain>In our study, a history of parenteral injections, past hospital admission, and age &gt;55 years were independent risk factors for HCV infection. </plain></SENT>
<SENT sid="574" pm="."><plain>Similar findings were reported in neighbouring Cameroon [10], Central African Republic [9], and the Republic of Congo [5]. </plain></SENT>
<SENT sid="575" pm="."><plain>These results confirm that the spread of HCV in central Africa is due to a cohort effect, with previous, possibly iatrogenic exposure. </plain></SENT>
<SENT sid="576" pm="."><plain>Iatrogenic events associated with massive and generalized therapy and/or vaccination have recently been shown to be a major cause of transmission of HCV in Egypt [3], Cameroon [7], [8], and the Central African Republic [9]. </plain></SENT>
<SENT sid="577" pm="."><plain>Such procedures were repeated annually, often with non-sterile equipment and serial arm-to-arm injections. </plain></SENT>
<SENT sid="578" pm="."><plain>The timing of these events is consistent with the pattern of age-dependent seroprevalence. </plain></SENT>
<SENT sid="579" pm="."><plain>More extensive epidemiological studies are needed to better characterize the route of transmission and dissemination of HCV in Gabon. </plain></SENT>
</text></p><p><text><SENT sid="580" pm="."><plain>This is the first large study of HCV molecular epidemiology in Gabon. </plain></SENT>
<SENT sid="581" pm="."><plain>Our phylogenetic analysis indicates the circulation of three HCV genotypes (1, 2 and 4), with a predominance of genotype 4. </plain></SENT>
<SENT sid="582" pm="."><plain>In a previous study in Gabon, only HCV genotype 4 was found [6], [28]. </plain></SENT>
<SENT sid="583" pm="."><plain>The current study documents that there is high diversity in genotypes 1 and 4 and many unsubtyped sequences. </plain></SENT>
<SENT sid="584" pm="."><plain>We [14], [31] and others [44] have reported the circulation of three HCV genotypes (1, 2 and 4) in neighbouring Cameroon and Central African Republic, with greater genetic diversity within genotype 4. </plain></SENT>
<SENT sid="585" pm="."><plain>HCV genotype 4 also predominated and exhibited wide genetic diversity in previous studies in Gabon [6], nearby Cameroon [31], the Central African Republic [14] and the Republic of Congo [5]. </plain></SENT>
<SENT sid="586" pm="."><plain>An interesting finding is the difference in the predominant HCV-4 subtype in these four countries: subtype 4f in Cameroon [31], subtype 4e in Gabon ([6] and this study), subtype 4k in the Central African Republic [14] and 4c/4r in the Republic of Congo [5]. </plain></SENT>
<SENT sid="587" pm="."><plain>These five HCV-4 subtypes thus represent the signature HCV infection in the corresponding country. </plain></SENT>
<SENT sid="588" pm="."><plain>Characterization of the full genomes of these subtypes is needed for correct classification and further studies. </plain></SENT>
</text></p><p><text><SENT sid="589" pm="."><plain>Phylogenetic concordance was found in all 59 strains in which both the NS5B and core regions were sequenced. </plain></SENT>
<SENT sid="590" pm="."><plain>Unlike in some previous reports [45]–[52], genotype/subtype recombinant sequences or dual genotype/subtype infection were not observed in this study, indicating that recombination is a rare event in HCV, as reported previously [53], [54]. </plain></SENT>
</text></p><p><text><SENT sid="591" pm="."><plain>The epidemic history of HCV-4e, -4f, -4c, -4t and -4r strains was studied with a coalescent approach to population genetics. </plain></SENT>
<SENT sid="592" pm="."><plain>The MRCA of subtype 4e in this study is older than that reported by Ndong-Atome et al. [6] in a remote village of Gabon. </plain></SENT>
<SENT sid="593" pm="."><plain>This suggests different epidemic histories of HCV-4e in Gabon, with different periods of introduction according to the administrative region. </plain></SENT>
<SENT sid="594" pm="."><plain>The MRCAs of subtypes 4f and 4c in this study are in the same range as that of Cameroon [15] and the Republic of Congo [5], suggesting a similar period of introduction. </plain></SENT>
<SENT sid="595" pm="."><plain>Interestingly, the MRCA of subtype 4k in this study is more recent than that reported by Njouom et al. [14] in a village in the Central African Republic, suggesting that this subtype was introduced into Gabon from that country. </plain></SENT>
<SENT sid="596" pm="."><plain>The similarities in the population histories of HCV-4 in Gabon, Cameroon, the Central African Republic, and the Republic of Congo, despite differences in the predominant subtype, suggest that medical interventions amplified the HCV-4 subtype, which was introduced into cohorts of patients during mass intravenous drug campaigns by mobile teams at health centers or in villages. </plain></SENT>
<SENT sid="597" pm="."><plain>Less common subtypes presumably correspond to those for which such amplification did not occur or which occurred only at the end of the era of massive administration of intravenous drugs, with fewer cycles of amplification. </plain></SENT>
</text></p><p><text><SENT sid="598" pm="."><plain>In conclusion, this study shows that, like neighbouring Cameroon, the Central African Republic, and the Republic of the Congo, Gabon has a high prevalence of HCV, especially among older people, and, moreover, that it is highly heterogeneic (ranging from 3.7% to 20.8%, depending on the area studied). </plain></SENT>
<SENT sid="599" pm="."><plain>Fourteen subtypes, including nine subtype 4 strains, were identified, suggesting that genotype 4, especially subtype 4e, which predominates, has been endemic for a long time in Gabon. </plain></SENT>
<SENT sid="600" pm="."><plain>Coalescence studies of subtypes 4e, 4f, and 4c with an epidemic profile indicate that they spread exponentially during the first part of the 20th century, probably due to iatrogenic transmission, as reported in previous studies. </plain></SENT>
<SENT sid="601" pm="."><plain>In contrast, the 4t and 4k populations did not reach growth equilibrium during this period and continue to spread. </plain></SENT>
<SENT sid="602" pm="."><plain>Further studies are required to identity the risk factors for transmission in the country. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="603" pm="."><plain>We thank Philippe Yaba, André Delicat, Paul Ngari and Philippe Engandja for technical help. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0042002-Shepard1"><text><SENT sid="604" pm="."><plain>1 ShepardC, FinelliI, AlterM (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558–567.16122679 </plain></SENT>
</text></ref><ref id="pone.0042002-World1"><text><SENT sid="605" pm="."><plain>2World Health Organization (2010) The global burden of diseases: 2004 update. </plain></SENT>
<SENT sid="606" pm="."><plain>Annex A. </plain></SENT>
<SENT sid="607" pm="."><plain>Deaths and DALYs 2004. </plain></SENT>
<SENT sid="608" pm="."><plain>Geneva. </plain></SENT>
<SENT sid="609" pm="."><plain>Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_Annex">http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_Annex</ext-link> A.pdf. </plain></SENT>
<SENT sid="610" pm="."><plain>Accessed 2010 Dec 14. </plain></SENT>
</text></ref><ref id="pone.0042002-Frank1"><text><SENT sid="611" pm="."><plain>3 FrankC, MohamedM, StricklandG, LavanchyD, ArthurR, et al (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355: 887–891.10752705 </plain></SENT>
</text></ref><ref id="pone.0042002-Madhava1"><text><SENT sid="612" pm="."><plain>4 MadhavaV, BurgessC, DruckerE (2002) Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2: 293–302.12062995 </plain></SENT>
</text></ref><ref id="pone.0042002-Cantaloube1"><text><SENT sid="613" pm="."><plain>5 CantaloubeJ, GallianP, BokiloA, JordierF, BiaginiP, et al (2010) Analysis of hepatitis C virus strains circulating in Republic of the Congo. J Med Virol 82: 562–567.20166180 </plain></SENT>
</text></ref><ref id="pone.0042002-NdongAtome1"><text><SENT sid="614" pm="."><plain>6 Ndong-AtomeG, MakuwaM, Ouwe-Missi-Oukem-BoyerO, PybusO, BrangerM, et al (2008) High prevalence of hepatitis C virus infection and predominance of genotype 4 in rural Gabon. J Med Virol 80: 1581–1587.18649323 </plain></SENT>
</text></ref><ref id="pone.0042002-Nerrienet1"><text><SENT sid="615" pm="."><plain>7 NerrienetE, PouillotR, LachenalG, NjouomR, MfoupouendounJ, et al (2005) Hepatitis C virus infection in Cameroon: A cohort-effect. J Med Virol 76: 208–214.15834878 </plain></SENT>
</text></ref><ref id="pone.0042002-Njouom1"><text><SENT sid="616" pm="."><plain>8 NjouomR, PasquierC, AyoubaA, GessainA, FromentA, et al (2003) High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol 71: 219–225.12938196 </plain></SENT>
</text></ref><ref id="pone.0042002-Ppin1"><text><SENT sid="617" pm="."><plain>9 PépinJ, LabbéA, Mamadou-YayaF, MbélessoP, MbadingaïS, et al (2010) Iatrogenic transmission of human T cell lymphotropic virus type 1 and hepatitis C virus through parenteral treatment and chemoprophylaxis of sleeping sickness in colonial Equatorial Africa. Clin Infect Dis 51: 777–784.20735238 </plain></SENT>
</text></ref><ref id="pone.0042002-Ppin2"><text><SENT sid="618" pm="."><plain>10 PépinJ, LavoieM, PybusO, PouillotR, FoupouapouognigniY, et al (2010) Risk factors for hepatitis C virus transmission in colonial Cameroon. Clin Infect Dis 51: 768–776.20735242 </plain></SENT>
</text></ref><ref id="pone.0042002-Simmonds1"><text><SENT sid="619" pm="."><plain>11 SimmondsP, BukhJ, CombetC, DeléageG, EnomotoN, et al (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42: 962–973.16149085 </plain></SENT>
</text></ref><ref id="pone.0042002-Pybus1"><text><SENT sid="620" pm="."><plain>12 PybusO, BarnesE, TaggartR, LemeyP, MarkovP, et al (2009) Genetic history of hepatitis C virus in East Asia. J Virol 83: 1071–1082.18971279 </plain></SENT>
</text></ref><ref id="pone.0042002-Markov1"><text><SENT sid="621" pm="."><plain>13 MarkovP, PepinJ, FrostE, DeslandesS, LabbéA, et al (2009) Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa. J Gen Virol 90: 2086–2096.19474244 </plain></SENT>
</text></ref><ref id="pone.0042002-Njouom2"><text><SENT sid="622" pm="."><plain>14 NjouomR, FrostE, DeslandesS, Mamadou-YayaF, LabbéA, et al (2009) Predominance of hepatitis C virus genotype 4 infection and rapid transmission between 1935 and 1965 in the Central African Republic. J Gen Virol 90: 2452–2456.19535500 </plain></SENT>
</text></ref><ref id="pone.0042002-Njouom3"><text><SENT sid="623" pm="."><plain>15 NjouomR, NerrienetE, DuboisM, LachenalG, RoussetD, et al (2007) The hepatitis C virus epidemic in Cameroon: Genetic evidence for rapid transmission between 1920 and 1960. Infect Genet Evol 7: 361–367.17137845 </plain></SENT>
</text></ref><ref id="pone.0042002-Pouillot1"><text><SENT sid="624" pm="."><plain>16 PouillotR, LachenalG, PybusO, RoussetD, NjouomR (2008) Variable epidemic histories of hepatitis C virus genotype 2 infection in West Africa and Cameroon. Infect Genet Evol 8: 676–681.18599380 </plain></SENT>
</text></ref><ref id="pone.0042002-Simmonds2"><text><SENT sid="625" pm="."><plain>17 SimmondsP (2004) Genetic diversity and evolution of hepatitis C virus–15 years on. J Gen Virol 85: 3173–3188.15483230 </plain></SENT>
</text></ref><ref id="pone.0042002-Khan1"><text><SENT sid="626" pm="."><plain>18 KhanA, TanakaY, AzamZ, AbbasZ, KurbanovF, et al (2009) Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan. J Med Virol 81: 1189–1197.19475617 </plain></SENT>
</text></ref><ref id="pone.0042002-Magiorkinis1"><text><SENT sid="627" pm="."><plain>19 MagiorkinisG, MagiorkinisE, ParaskevisD, HoS, ShapiroB, et al (2009) The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med 6: e1000198.20041120 </plain></SENT>
</text></ref><ref id="pone.0042002-Mathe1"><text><SENT sid="628" pm="."><plain>20 MatheïC, Van DoorenS, LemeyP, Van DammeP, BuntinxF, et al (2008) The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium. J Viral Hepat 15: 399–408.18248334 </plain></SENT>
</text></ref><ref id="pone.0042002-Nakano1"><text><SENT sid="629" pm="."><plain>21 NakanoT, LuL, LiuP, PybusO (2004) Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis 190: 1098–1108.15319860 </plain></SENT>
</text></ref><ref id="pone.0042002-Pybus2"><text><SENT sid="630" pm="."><plain>22 PybusO, CharlestonM, GuptaS, RambautA, HolmesE, et al (2001) The epidemic behavior of the hepatitis C virus. Science 292: 2323–2325.11423661 </plain></SENT>
</text></ref><ref id="pone.0042002-Pybus3"><text><SENT sid="631" pm="."><plain>23 PybusO, CochraneA, HolmesE, SimmondsP (2005) The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol 5: 131–139.15639745 </plain></SENT>
</text></ref><ref id="pone.0042002-Tanaka1"><text><SENT sid="632" pm="."><plain>24 TanakaY, HanadaK, MizokamiM, YeoA, ShihJ, et al (2002) A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA 99: 15584–15589.12438687 </plain></SENT>
</text></ref><ref id="pone.0042002-Hauri1"><text><SENT sid="633" pm="."><plain>25 HauriA, ArmstrongG, HutinY (2004) The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 15: 7–16.14769164 </plain></SENT>
</text></ref><ref id="pone.0042002-Tanaka2"><text><SENT sid="634" pm="."><plain>26 TanakaY, HanadaK, OritoE, AkahaneY, ChayamaK, et al (2005) Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan. J Hepatol 42: 47–53.15629506 </plain></SENT>
</text></ref><ref id="pone.0042002-Delaporte1"><text><SENT sid="635" pm="."><plain>27 DelaporteE, ThiersV, DazzaM, RomeoR, Mlika-CabanneN, et al (1993) High level of hepatitis C endemicity in Gabon, equatorial Africa. Trans R Soc Trop Med Hyg 87: 636–637.7507606 </plain></SENT>
</text></ref><ref id="pone.0042002-Xu1"><text><SENT sid="636" pm="."><plain>28 XuL, LarzulD, DelaporteE, BréchotC, KremsdorfD (1994) Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J Gen Virol 75: 2393–2398.8077938 </plain></SENT>
</text></ref><ref id="pone.0042002-Becquart1"><text><SENT sid="637" pm="."><plain>29 BecquartP, WauquierN, MahlakõivT, NkogheD, PadillaC, et al (2010) High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One 5: e9126.20161740 </plain></SENT>
</text></ref><ref id="pone.0042002-Njouom4"><text><SENT sid="638" pm="."><plain>30 NjouomR, PasquierC, AyoubaA, Sandres-SaunéK, MfoupouendounJ, et al (2003) Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: prevalence, viremia, and genotypes. J Med Virol 69: 384–390.12526049 </plain></SENT>
</text></ref><ref id="pone.0042002-Pasquier1"><text><SENT sid="639" pm="."><plain>31 PasquierC, NjouomR, AyoubaA, DuboisM, SartreM, et al (2005) Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J Med Virol 77: 390–398.16173014 </plain></SENT>
</text></ref><ref id="pone.0042002-Thompson1"><text><SENT sid="640" pm="."><plain>32 ThompsonJ, GibsonT, PlewniakF, JeanmouginF, HigginsD (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876–4882.9396791 </plain></SENT>
</text></ref><ref id="pone.0042002-Tamura1"><text><SENT sid="641" pm="."><plain>33 TamuraK, PetersonD, PetersonN, StecherG, NeiM, et al (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731–2739.21546353 </plain></SENT>
</text></ref><ref id="pone.0042002-Simmonds3"><text><SENT sid="642" pm="."><plain>34 SimmondsP, SmithD, McOmishF, YapP, KolbergJ, et al (1994) Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol 75: 1053–1061.8176367 </plain></SENT>
</text></ref><ref id="pone.0042002-Drummond1"><text><SENT sid="643" pm="."><plain>35 DrummondA, HoS, PhillipsM, RambautA (2006) Relaxed phylogenetics and dating with confidence. PLoS Biol 4: e88.16683862 </plain></SENT>
</text></ref><ref id="pone.0042002-Hibbs1"><text><SENT sid="644" pm="."><plain>36 HibbsR, CorwinA, HassanN, KamelM, DarwishM, et al (1993) The epidemiology of antibody to hepatitis C in Egypt. J Infect Dis 168: 789–790.8394867 </plain></SENT>
</text></ref><ref id="pone.0042002-Noguchi1"><text><SENT sid="645" pm="."><plain>37 NoguchiS, SataM, SuzukiH, MizokamiM, TanikawaK (1997) Routes of transmission of hepatitis C virus in an endemic rural area of Japan. </plain></SENT>
<SENT sid="646" pm="."><plain>Molecular epidemiologic study of hepatitis C virus infection. Scand J Infect Dis 29: 23–28.9112293 </plain></SENT>
</text></ref><ref id="pone.0042002-Shin1"><text><SENT sid="647" pm="."><plain>38 ShinH, KimJ, OhnoT, CaoK, MizokamiM, et al (2000) Prevalence and risk factors of hepatitis C virus infection among Koreans in rural area of Korea. Hepatol Res 17: 185–196.10794972 </plain></SENT>
</text></ref><ref id="pone.0042002-Tawaraya1"><text><SENT sid="648" pm="."><plain>39 TawarayaH, OhkoshiS, KuwanaK, WatanabeM, KamimuraT, et al (1995) Epidemiologic survey and genetic analysis of endemic hepatitis C virus infection in a Japanese town with a high prevalence of hepatitis B virus carriers. J Med Virol 45: 367–372.7545207 </plain></SENT>
</text></ref><ref id="pone.0042002-Yoshii1"><text><SENT sid="649" pm="."><plain>40 YoshiiE, ShinzawaH, SaitoT, ShaoL, KubokiM, et al (1999) Molecular epidemiology of hepatitis C virus infection in an area endemic for community-acquired acute hepatitis C. </plain></SENT>
<SENT sid="650" pm="."><plain>Tohoku J Exp Med. 188: 311–316. </plain></SENT>
</text></ref><ref id="pone.0042002-Alter1"><text><SENT sid="651" pm="."><plain>41 AlterM, MargolisH, KrawczynskiK, JudsonF, MaresA, et al (1992) The natural history of community-acquired hepatitis C in the United States. </plain></SENT>
<SENT sid="652" pm="."><plain>The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 327: 1899–1905.1280771 </plain></SENT>
</text></ref><ref id="pone.0042002-Shobokshi1"><text><SENT sid="653" pm="."><plain>42 ShobokshiO, SerebourF, Al-DreesA, MitwalliA, QahtaniA, et al (2003) Hepatitis C virus seroprevalence rate among Saudis. Saudi Med J 24: S81–86.12897907 </plain></SENT>
</text></ref><ref id="pone.0042002-VanDamme1"><text><SENT sid="654" pm="."><plain>43 Van DammeP, ThyssenA, Van LoockF (2002) Epidemiology of hepatitis C in Belgium: present and future. Acta Gastroenterol Belg 65: 78–79.12148442 </plain></SENT>
</text></ref><ref id="pone.0042002-Ndjomou1"><text><SENT sid="655" pm="."><plain>44 NdjomouJ, PybusO, MatzB (2003) Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol 84: 2333–2341.12917453 </plain></SENT>
</text></ref><ref id="pone.0042002-Bhattacharya1"><text><SENT sid="656" pm="."><plain>45 BhattacharyaD, AccolaM, AnsariI, StrikerR, RehrauerW (2011) Naturally occurring genotype 2b/1a hepatitis C virus in the United States. Virol J 8: 458.21967740 </plain></SENT>
</text></ref><ref id="pone.0042002-Colina1"><text><SENT sid="657" pm="."><plain>46 ColinaR, CasaneD, VasquezS, García-AguirreL, ChungaA, et al (2004) Evidence of intratypic recombination in natural populations of hepatitis C virus. J Gen Virol 85: 31–37.14718617 </plain></SENT>
</text></ref><ref id="pone.0042002-GonzlezCandelas1"><text><SENT sid="658" pm="."><plain>47 González-CandelasF, López-LabradorF, BrachoM (2011) Recombination in hepatitis C virus. Viruses 3: 2006–2024.22069526 </plain></SENT>
</text></ref><ref id="pone.0042002-Kageyama1"><text><SENT sid="659" pm="."><plain>48 KageyamaS, AgdamagD, AlesnaE, LeañoP, HerediaA, et al (2006) A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol 78: 1423–1428.16998890 </plain></SENT>
</text></ref><ref id="pone.0042002-Kalinina1"><text><SENT sid="660" pm="."><plain>49 KalininaO, NorderH, MukomolovS, MagniusL (2002) A natural intergenotypic recombinant of hepatitis C virus identified in St Petersburg. J Virol 76: 4034–4043.11907242 </plain></SENT>
</text></ref><ref id="pone.0042002-Kurbanov1"><text><SENT sid="661" pm="."><plain>50 KurbanovF, TanakaY, AvazovaD, KhanA, SugauchiF, et al (2008) Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan. Hepatol Res 38: 457–464.18034826 </plain></SENT>
</text></ref><ref id="pone.0042002-LegrandAbravanel1"><text><SENT sid="662" pm="."><plain>51 Legrand-AbravanelF, ClaudinonJ, NicotF, DuboisM, Chapuy-RegaudS, et al (2007) New natural intergenotypic (2/5) recombinant of hepatitis C virus. J Virol 81: 4357–4362.17267503 </plain></SENT>
</text></ref><ref id="pone.0042002-Noppornpanth1"><text><SENT sid="663" pm="."><plain>52 NoppornpanthS, LienT, PoovorawanY, SmitsS, OsterhausA, et al (2006) Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 80: 7569–7577.16840336 </plain></SENT>
</text></ref><ref id="pone.0042002-Viazov1"><text><SENT sid="664" pm="."><plain>53 ViazovS, RossS, KyuregyanK, TimmJ, Neumann-HaefelinC, et al (2010) Hepatitis C virus recombinants are rare even among intravenous drug users. J Med Virol 82: 232–238.20029799 </plain></SENT>
</text></ref><ref id="pone.0042002-Zhou1"><text><SENT sid="665" pm="."><plain>54 ZhouY, WangX, HongG, TanZ, ZhuY, et al (2010) Natural intragenotypic and intergenotypic HCV recombinants are rare in southwest China even among patients with multiple exposures. J Clin Virol 49: 272–276.20850377 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
